pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
GLM-101
Congenital Disorder of Glycosylation Type I A
Glycomine Inc
0 catalysts
Preclinical
GLR-2007
Malignant Glioma
Gan & Lee Pharmaceuticals Co Ltd
0 catalysts
Phase 2
GLY-200
Type 2 Diabetes
Glyscend Inc
0 catalysts
GLYBURIDE AND METFORMIN HYDROCHLORIDE
GLYBURIDE AND METFORMIN HYDROCHLORIDE (GLYBURIDE AND METFORMIN HYDROCHLORIDE)
AUROBINDO PHARMA
← prev
page 100 of 271
next →
131
Pain89
Neurology1
0 catalysts
GLYXAMBI
GLYXAMBI (EMPAGLIFLOZIN)
Boehringer Ingelheim Corp
0 catalysts
Preclinical
GM-0111
Oral Mucositis
GlycoMira Therapeutics Inc
0 catalysts
Phase 1
GM-60106
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
JD Bioscience Inc
0 catalysts
Phase 1
GMA-301
Pulmonary Arterial Hypertension
Gmax Biopharm LLC
0 catalysts
Phase 1
GNS-3545
Idiopathic Pulmonary Fibrosis
Genosco Inc
0 catalysts
Phase 1
GNSC-001
Osteoarthritis
Genascence Corp
0 catalysts
Phase 2
GNT-0003
Crigler-Najjar Syndrome
Genethon SA
0 catalysts
Preclinical
GNT-0008
Limb-Girdle Muscular Dystrophy
Atamyo Therapeutics SAS
0 catalysts
Phase 1
GNTI-122
Type 1 Diabetes (Juvenile Diabetes)
GentiBio Inc
0 catalysts
Preclinical
GNTbm-TKI
Neuroendocrine Tumors
Great Novel Therapeutics Biotech & Medicals Corp
0 catalysts
Phase 2
GO-2032c
Refractory Acute Myeloid Leukemia
Genus Oncology LLC
0 catalysts
GOLYTELY
GOLYTELY (POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE)
AZURITY
0 catalysts
GOZELLIX
GOZELLIX (GOZETOTIDE)
TELIX INNOVATIONS
0 catalysts
Preclinical
GP-119
Alzheimer's Disease
GliaPharm SA
0 catalysts
Phase 3
GP-2
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
Vascular endothelial growth factor A, long form
$GLSIGreenwich LifeSciences, Inc.
0 catalysts
Phase 2
GP-531
Congestive Heart Failure (Heart Failure)
ViCardia Therapeutics Inc
0 catalysts
Preclinical
GPX-002
Type 1 Diabetes (Juvenile Diabetes)
$GNPXGenprex, Inc.
0 catalysts
Phase 1
GRC-39815
Chronic Obstructive Pulmonary Disease (COPD)
Glenmark Pharmaceuticals Ltd
0 catalysts
Phase 2
GRC-54276
Bile Duct Cancer (Cholangiocarcinoma)
Ichnos Glenmark Innovation
0 catalysts
Phase 2
GRF-312
Keratoconjunctivitis Sicca (Dry Eye)
$GRFSGrifols SA
0 catalysts
Preclinical
GRI-0803
Systemic Lupus Erythematosus
$GRIGRI Bio, Inc.
0 catalysts
Phase 1
GRN-300
Triple-Negative Breast Cancer (TNBC)
Greenfire Bio LLC
0 catalysts
Phase 2
GS-030
Retinitis Pigmentosa (Retinitis)
GenSight Biologics SA
0 catalysts
Phase 1
GS-0321
Solid Tumor
$GILDGILEAD SCIENCES, INC.
0 catalysts
Phase 3
GS-100
Grace Science LLC
0 catalysts
Phase 1
GS-6791
Rheumatoid Arthritis
$GILDGILEAD SCIENCES, INC.
0 catalysts